TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Singular Health Group Ltd ( (AU:SHG) ) has shared an update.
Singular Health Group Ltd has announced the issuance of 509,091 fully paid ordinary shares following the exercise of unlisted options, raising $50,909.10. This move signifies the company’s ongoing efforts to strengthen its financial position and enhance its market operations, potentially benefiting stakeholders by increasing the liquidity and visibility of its shares.
The most recent analyst rating on (AU:SHG) stock is a Sell with a A$0.50 price target. To see the full list of analyst forecasts on Singular Health Group Ltd stock, see the AU:SHG Stock Forecast page.
More about Singular Health Group Ltd
Singular Health Group Ltd is a Western Australian medical technology company listed on the ASX, focused on creating an integrated healthcare ecosystem. Their primary product, the 3Dicom software, empowers patients and practitioners by enhancing the visualization and understanding of medical imaging data. The 3Dicom MD is cleared for diagnostic use in the United States, highlighting its market relevance.
Average Trading Volume: 816,946
Technical Sentiment Signal: Buy
Current Market Cap: A$90.64M
See more insights into SHG stock on TipRanks’ Stock Analysis page.